The FDA granted fast track designation for CTx001, an investigational gene therapy candidate for geographic atrophy secondary ...

Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...

Pegcetacoplan significantly reduces proteinuria in patients with recurrent C3 glomerulopathy, or primary immune-complex ...

US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...

For detailed technical data, case studies and solution proposals, the full product and solutions portfolio is available at https://en.zozen.com/, where potential customers can further evaluate whether ...

While it is legitimate to disagree with policy direction, disagreements should not be framed as errors or gaps. KPMG would ...

A nanomaterial based on a platform developed by Professor Samuel Stupp crosses the blood-brain barrier and targets harmful ...

For AI to reach its full potential in classrooms, it requires visionary leaders at every level, from governments to schools ...

Sip your way through North Carolina’s mountain towns with this guide to hidden-gem cafés: cozy vibes, great coffee, and local ...

South Africa soon plans to extend the five-year validity period of driving licence and is busy developing a digital permit to ...

Dallas, Texas - January 08, 2026 - PRESSADVANTAGE - Longhorn Reels, a Texas-based manufacturer with over 46 years of ...

NEW YORK CITY, NY, UNITED STATES, January 6, 2026 /EINPresswire.com/ -- ViolationWatch today announced the launch of ...